Clinical Trials Browser

Phase 3 × Leukemia × idelalisib × Clear all

NCT01569295 2020-03-10

Tugela

Phase 3 Completed

416 enrolled 16 charts

LymphoidOther hematologic neoplasm

Leukemia, Leukemia, Lymphocytic, Chronic, B-Cell

NCT01539291 2019-08-20

Extension Study of Idelalisib in Participants With Chronic Lymphocytic Leukemia (CLL) Who Participated in GS-US-312-0116 (NCT01539512)

Phase 3 Terminated

161 enrolled 34 charts

LymphoidOther hematologic neoplasm

Leukemia, Leukemia, Lymphocytic, Chronic, B-Cell